Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar:224:108651.
doi: 10.1016/j.clim.2020.108651. Epub 2020 Dec 14.

Interrelations between COVID-19 and other disorders

Amin Gasmi  1 , Massimiliano Peana  2 , Lyudmila Pivina  3 , Shvetha Srinath  1 , Asma Gasmi Benahmed  4 , Yuliya Semenova  3 , Alain Menzel  5 , Maryam Dadar  6 , Geir Bjørklund  7
Affiliations
Review

Interrelations between COVID-19 and other disorders

Amin Gasmi et al. Clin Immunol. 2021 Mar.

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory tract virus that causes Coronavirus disease (COVID-19). The virus originated in Wuhan, China, in December 2019 and has spread across the globe to-date. The disease ranges from asymptomatic carriers to symptoms such as fever, sore throat, cough, lung infections, and in severe cases, acute respiratory distress syndrome, sepsis, and death. As many as 50% of patients reported having at least one comorbidities with COVID-19 upon hospital admission. Hypertension, diabetes, chronic obstructive pulmonary disease, obesity, and cardiovascular diseases are among the most commonly reported. Comorbidities are contributing to acute disease prognosis and increased risk of severe symptoms. Around 70% of patients who require ICU care have been observed to have comorbidities. This review intends to understand how some of these comorbidities affect the disease's prognosis and how severe the outcome can be expected.

Keywords: Asthma; COVID-19; Cardiovascular diseases; Comorbidities; Diabetes; Hypertension; Novel coronavirus; Preexisting condition; SARS-CoV-2 outcome; Severe outcome.

PubMed Disclaimer

Conflict of interest statement

The authors declare they have no actual or potential competing financial interests.

Figures

Unlabelled Image
Graphical abstract
Fig. 1
Fig. 1
Percentage of hospitalization and mortality by age among COVID-19 patients, according to data from Centers for Disease Control and Prevention [9].
Fig. 2
Fig. 2
Interrelation between severe Covid-19 and comorbidities/conditions
See this image and copyright information in PMC

References

    1. Whitworth J. COVID-19: a fast evolving pandemic. Trans R Soc Trop Med Hyg. 2020;114:241–248. doi: 10.1093/trstmh/traa025. - DOI - PMC - PubMed
    1. Cascella M., Rajnik M., Cuomo A., Dulebohn S.C., Di Napoli R. StatPearls; Treasure Island (FL): 2020. Features, Evaluation and Treatment Coronavirus (COVID-19) - PubMed
    1. Sun J., He W.T., Wang L., Lai A., Ji X., Zhai X., Li G., Suchard M.A., Tian J., Zhou J., Veit M., Su S. COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives. Trends Mol Med. 2020;26:483–495. doi: 10.1016/j.molmed.2020.02.008. - DOI - PMC - PubMed
    1. Bai Y., Yao L., Wei T., Tian F., Jin D.-Y., Chen L., Wang M. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020;323:1406–1407. - PMC - PubMed
    1. Adhikari S.P., Meng S., Wu Y.J., Mao Y.P., Ye R.X., Wang Q.Z., Sun C., Sylvia S., Rozelle S., Raat H., Zhou H. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020;9:29. doi: 10.1186/s40249-020-00646-x. - DOI - PMC - PubMed